JClue, yes and let's not forget Damaj brought Apricus pharma to $6 per share, moreso due to reverse splits, rather than increased sales or increases profits.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.